Bleocin Injection

A qualified oncology team administers it by intramuscular, intravenous, or subcutaneous injection.

Bleocin 15mg Injection Ingredients and Usage

Bleocin 15mg Injection contains bleomycin sulphate, a cytotoxic glycopeptide antibiotic belonging to the antitumor antibiotic drug class. Oncologists prescribe it as part of the ABVD combination regimen for Hodgkin lymphoma and for testicular cancer.

Bleocin 15mg Injection also treats squamous cell carcinoma of the head, neck, skin, cervix, penis, and vulva, and is used to manage malignant pleural effusions caused by cancer. Unlike many chemotherapy agents, it causes minimal bone marrow suppression, which supports its use in combination regimens.

How Does Bleocin 15mg Injection Work?

Bleomycin binds to DNA and, in the presence of oxygen and metal ions, generates free radicals that cause single and double strand breaks in the DNA of cancer cells. This direct DNA damage is difficult for cells to repair.

By fragmenting DNA in this way, Bleocin 15mg Injection prevents cancer cells from dividing and triggers cell death. Because this mechanism does not rely heavily on bone marrow activity, it is often combined with other chemotherapy drugs that do cause significant myelosuppression.

Bleocin 15mg Injection Side Effects

Bleocin 15mg Injection commonly causes fever, skin, and mucous membrane side effects, occurring in roughly half of treated patients.

• Fever and chills, often within hours of the dose

• Skin redness, rash, or hardening

• Hyperpigmentation

• Nail changes

• Hair thinning

• Mouth sores

• Loss of appetite

Warnings

• Bleocin 15mg Injection carries a boxed warning for pulmonary fibrosis, its most severe toxicity; risk rises with age over 70 and cumulative doses above 400 units, but it has occurred in young patients at low doses. Regular chest X-rays and lung function monitoring are recommended.

• An idiosyncratic reaction resembling anaphylaxis, with low blood pressure, confusion, fever, chills, and wheezing, occurs in about 1 percent of lymphoma patients, usually after the first or second dose; close monitoring is essential during early treatment.

• Avoid high concentrations of supplemental oxygen during and after treatment, including during surgery, since this can trigger or worsen bleomycin related lung injury.

• Bleocin 15mg Injection is contraindicated in patients who have had a prior hypersensitive or idiosyncratic reaction to it.

• Use with caution in patients with pre-existing lung disease or those who have received chest radiation, since these increase pulmonary toxicity risk.

• Bleocin 15mg Injection is not recommended in pregnancy or breastfeeding unless clearly necessary; discuss risks and benefits with a specialist.

• Use with caution in patients with kidney impairment, since reduced clearance can increase toxicity.

Bleocin 15mg Injection Storage Conditions

Store Bleocin 15mg Injection refrigerated between 2°C and 8°C, and do not freeze. Keep the vial in its original packaging until immediately before use. Store this medicine out of reach of children and ensure only trained healthcare staff handle preparation and administration.